有晶状体眼后房型人工晶状体植入治疗屈光不正的研究进展

屈光不正(refractive errors)是常见的眼科疾病,可以通过配镜、激光屈光手术等方法为患者进行矫正,但是这些方法对高度屈光不正、圆锥角膜等疾病的治疗有一定的局限性。有晶状体眼后房型人工晶状体(ICL)植入术是矫正屈光不正的主要方式之一,目前主要应用于矫正高度近视和散光,为探讨ICL植入术矫正低、中、高度近视及远视等的安全性和有效性,本文将会对ICL植入术矫正屈光不正的研究进展进行综述。

Progress of posterior chamber implantable collamer lens implantation for the treatment of refractive errors

Refractive errors are a common ophthalmic disease, which can be corrected by wearing glasses, laser refractive surgery and so on. However, there are some limitations of these methods for treating high myopia, keratoconus, etc. The implantation of the posterior chamber implantable collamer lens(ICL)is one of the most common surgry for correcting refractive errors(mainly apply to high myopia and astigmatism). This study aim to explore the safety and effectiveness of implanting ICL to correct low to moderate and high myopia or hyperopia. This review will summarize the research progress of implanting ICL to correct refractive errors.